• Login
Saturday, February 21, 2026
Geneva Times
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
Geneva Times
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
Home Business

BTIG lowers Tvardi Therapeutics stock price target to $15 on IPF trial setback

GenevaTimes by GenevaTimes
October 13, 2025
in Business
Reading Time: 1 min read
0
BTIG lowers Tvardi Therapeutics stock price target to on IPF trial setback
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter



BTIG lowers Tvardi Therapeutics stock price target to $15 on IPF trial setback
BTIG lowers Tvardi Therapeutics stock price target to $15 on IPF trial setback

Read More

Previous Post

Gaza hostages reunite with families after two years

 Next Post

Spain to use AI to cut out corruption
Next Post
Spain to use AI to cut out corruption

Spain to use AI to cut out corruption

ADVERTISEMENT
Facebook Twitter Instagram Youtube LinkedIn

Explore the Geneva Times

  • About us
  • Contact us

Contact us:

editor@thegenevatimes.ch

Visit us

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin